IL58489A0 - The production of oxymorphone - Google Patents

The production of oxymorphone

Info

Publication number
IL58489A0
IL58489A0 IL58489A IL5848979A IL58489A0 IL 58489 A0 IL58489 A0 IL 58489A0 IL 58489 A IL58489 A IL 58489A IL 5848979 A IL5848979 A IL 5848979A IL 58489 A0 IL58489 A0 IL 58489A0
Authority
IL
Israel
Prior art keywords
oxymorphone
production
Prior art date
Application number
IL58489A
Other languages
English (en)
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL58489A0 publication Critical patent/IL58489A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL58489A 1978-10-19 1979-10-18 The production of oxymorphone IL58489A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
IL58489A0 true IL58489A0 (en) 1980-01-31

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58489A IL58489A0 (en) 1978-10-19 1979-10-18 The production of oxymorphone

Country Status (16)

Country Link
JP (1) JPS55501025A (xx)
AU (1) AU5189779A (xx)
BE (1) BE879494A (xx)
CA (1) CA1108132A (xx)
CS (1) CS211364B2 (xx)
DK (1) DK258280A (xx)
ES (1) ES485154A1 (xx)
FI (1) FI793235A (xx)
FR (1) FR2439201A1 (xx)
GB (1) GB2049680A (xx)
IL (1) IL58489A0 (xx)
IT (1) IT7969032A0 (xx)
NL (1) NL7920126A (xx)
NO (1) NO793297L (xx)
SE (1) SE8004454L (xx)
WO (1) WO1980000841A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
JP2694156B2 (ja) * 1989-10-16 1997-12-24 アメリカ合衆国 N−ノル中間体を介するノルテバイン、ノルモルフィン、ノルオキシモルフォン鏡像異性体の全合成
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20030130297A1 (en) 2001-07-06 2003-07-10 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007103105A2 (en) 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
BR112012001244A2 (pt) 2009-07-22 2020-12-08 Gruünenthal Gmbh Forma de dosagem resitente à adulteração, seu processo de produção, e embalagem contendo tal forma
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
JP5925779B2 (ja) 2010-09-02 2016-05-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 無機塩を含む不正使用抵抗性剤形
JP2014524925A (ja) 2011-07-29 2014-09-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
MX362357B (es) 2012-04-18 2019-01-14 Gruenenthal Gmbh Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
CA2931553C (en) 2013-11-26 2022-01-18 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
MX2016015417A (es) 2014-05-26 2017-02-22 Gruenenthal Gmbh Multiparticulas protegidas contra vertido de dosis etanolico.
CA2983642A1 (en) 2015-04-24 2016-10-27 Grunenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
JPS55501025A (xx) 1980-11-27
ES485154A1 (es) 1980-06-16
BE879494A (fr) 1980-02-15
NL7920126A (nl) 1980-08-29
DK258280A (da) 1980-06-17
IT7969032A0 (it) 1979-10-18
WO1980000841A1 (en) 1980-05-01
CS211364B2 (en) 1982-02-26
CA1108132A (en) 1981-09-01
FI793235A (fi) 1980-04-20
GB2049680A (en) 1980-12-31
NO793297L (no) 1980-04-22
AU5189779A (en) 1980-04-24
FR2439201A1 (fr) 1980-05-16
SE8004454L (sv) 1980-06-16

Similar Documents

Publication Publication Date Title
IL58489A0 (en) The production of oxymorphone
GB2017101B (en) Production of maytansinoids
JPS54105273A (en) Production of riceecracker
JPS5523999A (en) Production of 66aminoo 66deoxyyllsolbose
JPS54109932A (en) Manufacture of fluorobenzol
GB2015992B (en) Manufacture of para-nitro-diphenylamines
JPS54132575A (en) Manufacture of tetrahydrobenzoxocin
GB2012276B (en) Producing cephalosporins
GB2022083B (en) Production of iso-alpha-acids
JPS54109924A (en) Manufacture of silylphosphate
GB2015997B (en) Production of nitrodiarylamines
JPS54163538A (en) Production of salycilaldehydes
GB2015427B (en) Production of laminates
IL56245A (en) 8 -alkyl-substituted morphinan-6-one compounds and their production
JPS54100322A (en) Manufacture of nnacyltaurine
JPS54122243A (en) Manufacture of 22nitrobenzaldehyde
JPS54131600A (en) Manufacture of borazin
IL58568A (en) Manufacture of 5-cyano-4-methyloxazole
JPS54135737A (en) Manufacture of trifluoromethylphenols
JPS54143495A (en) Production of polyvinylpyrolidoneeiodine
IL58941A (en) Production of phenyl-2-fluoroacrylate
IL57174A (en) Manufacture of alpha-chloroacetoacetamides
GB2014178B (en) Halogenoantyraquinone compounds and the production and usethereof
JPS54128530A (en) Manufacture of ppaminoodiphenylamine
JPS54112858A (en) Manufacture of 22pyrrolidone